Compare ARGX & VG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
Venture Global operates two liquified natural gas, or LNG, production facilities in Louisiana. It has pioneered the use of smaller, factory-built equipment producing unexpectedly high yields. With a substantial development plan it seeks to become a vertically integrated LNG producer and supplier to end consumers around the world.